Patent US5624803A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5624803A Expired / Lapsed US ⏱️ 0.0 years remaining

In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom

Assignee: University of California
•
Filing: 1994-10-13
•
Granted: 1997-04-29
•
Expires: 2014-10-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention encompasses improved methods and materials for the delivering of antisense, triplex, and/or ribozyme oligonucleotides intracellularly, and RNA polymerase III-based constructs termed "oligonucleotide generators" to accomplish the delivery of oligonucleotides. Also encompassed by the present invention are methods for screening oligonucleotide sequences that are candidates for triplex formation.

Inventors

  • 👤 Sarah B. Noonberg
  • 👤 C. Anthony Hunt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 20:01
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6839; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/111; C12N15/113; C12N15/1138; C12P; C12P19/00; C12P19/26; C12P19/28; C12P19/30; C12P19/34; C12Q1/6834; C12N2310/00; C12N2310/10; C12N2310/11; C12N2310/111; C12N2310/15; C12N2320/00; C12N2320/50; C12N2320/51; C12N2330/00; C12N2330/30

Claims Analysis

Total Claims: 33
Claim 1
Independent Claim 68 words
A construct for generating a specific oligonucleotide within a cell, which construct comprises a nucleotide sequence from which the transcript is the specific oligonucleotide, said nucleotide sequence being flanked in the 5' direction by a stabilizing region and in the 3' direction by a termination sequence, and a promoter, which initiates transcription by RNA polymerase III, and which promoter is in the 5' direction from the stabilizing region.
Claim 2
Dependent Claim 68 words
A construct for generating a specific oligonucleotide within a cell, which construct comprises a nucleotide sequence from which the transcript is the specific oligonucleotide, said nucleotide sequence being flanked in the 5' direction by a stabilizing region and in the 3' direction by a termination sequence, and a promoter, which initiates transcription by RNA polymerase III, and which promoter is in the 5' direction from the stabilizing region.
Claim 3
Dependent Claim 65 words
An oligonucleotide generator, comprising from 5' to 3': (a) an U6-type RNA polymerase III promoter; (b) a specific nucleotide sequence from which a specific oligonucleotide can be transcribed; and (c) a termination sequence; wherein the components of the oligonucleotide generator are operably linked; and wherein the oligonucleotide generator is capable of being transcribed by RNA polymerase III to produce a transcript comprising the specific oligonucleotide.
Claim 4
Dependent Claim 65 words
An oligonucleotide generator, comprising from 5' to 3': (a) an U6-type RNA polymerase III promoter; (b) a specific nucleotide sequence from which a specific oligonucleotide can be transcribed; and (c) a termination sequence; wherein the components of the oligonucleotide generator are operably linked; and wherein the oligonucleotide generator is capable of being transcribed by RNA polymerase III to produce a transcript comprising the specific oligonucleotide.
Claim 5
Dependent Claim 72 words
The oligonucleotide generator of claim 2, further comprising: a stabilizing region from which a first hairpin-forming sequence can be transcribed; wherein the stabilizing region is operably linked and positioned between the U6-type RNA polymerase III promoter and the specific nucleotide sequence; and wherein the oligonucleotide generator is capable of being transcribed by RNA polymerase III to produce a transcript comprising from 5' to 3' the first hairpin-forming sequence and the specific oligonucleotide.
Claim 6
Dependent Claim 67 words
The oligonucleotide generator of claim 3, further comprising a capping segment; wherein the capping segment is operably linked and positioned between the stabilizing region and the specific nucleotide sequence; and wherein the oligonucleotide generator is capable of being transcribed by RNA polymerase III to produce a transcript comprising from 5' to 3' the first hairpin-forming sequence, a capping segment of AUAUCC or AUAUAC, and the specific oligonucleotide.
Claim 7
Dependent Claim 26 words
The oligonucleotide generator of claim 4, wherein the first hairpin-forming sequence of the transcript consist of the first 20 nucleotides of the naturally-occurring human U6 transcript.
Claim 8
Dependent Claim 16 words
The oligonucleotide generator of claim 4, wherein the capping segment of the RNA transcript is AUAUAC.
Claim 9
Dependent Claim 65 words
The oligonucleotide generator of claim 2, wherein the U6-type RNA polymerase III promoter is selected from the group consisting of the U6 promoter, the 7SK promoter, the H1 RNA gene promoter, the plant U3 snRNA gene promoter, the MRP gene promoter, and recombinant promoters thereof, which recombinant promoters are capable of initiating transcription by RNA polymerase III from a position upstream of the transcribed DNA.
Claim 10
Dependent Claim 18 words
The oligonucleotide generator of claim 7, wherein the U6-type RNA polymerase III promoter is the human U6 promoter.
Claim 11
Dependent Claim 24 words
The oligonucleotide generator of claim 2, wherein the specific oligonucleotide is selected from the group consisting of antisense, triplex-forming, ribozyme oligonucleotides, and combinations thereof.
Claim 12
Dependent Claim 14 words
The oligonucleotide generator of claim 9, wherein the specific oligonucleotide is an antisense oligonucleotide.
Claim 13
Dependent Claim 14 words
The oligonucleotide generator of claim 9, wherein the specific oligonucleotide is a triplex-forming oligonucleotide.
Claim 14
Dependent Claim 14 words
The oligonucleotide generator of claim 9, wherein the specific oligonucleotide is a ribozyme oligonucleotide.
Claim 15
Dependent Claim 73 words
The oligonucleotide generator of claim 3, further comprising: a 3' tail from which a second hairpin-forming sequence can be transcribed; wherein the 3' tail is operably linked and positioned between the specific nucleotide sequence and the termination sequence; and wherein the oligonucleotide generator is capable of being transcribed by RNA polymerase III to produce a transcript comprising from 5' to 3' the first hairpin-forming sequence, the specific oligonucleotide, and the second hairpin-forming sequence.
Claim 16
Dependent Claim 98 words
The oligonucleotide generator of claim 3, further comprising: a 3' tail from which a lariat-forming sequence can be transcribed; wherein the 3' tail is operably linked and positioned between the specific nucleotide sequence and the termination sequence; wherein the oligonucleotide generator is capable of being transcribed by RNA polymerase III to produce a transcript comprising from 5' to 3' the first hairpin-forming sequence, the specific oligonucleotide, and the lariat-forming sequence; and wherein the transcript is predicted to from a stable lariat structure by Watson-Crick base pairing between the nucleotides of the first hairpin-forming region and the lariat-forming region.
Claim 17
Dependent Claim 135 words
The oligonucleotide generator of claim 2, further comprising: a 5' tail from which a first lariat-forming sequence can be transcribed; and a 3' tail from which a second lariat-forming sequence can be transcribed; wherein the 5' tail is operably linked and positioned between the U6-type RNA polymerase III promoter and the specific nucleotide sequence; wherein the 3' tail is operably linked and positioned between the specific nucleotide sequence and the termination sequence; wherein the oligonucleotide generator is capable of being transcribed by RNA polymerase III to produce a transcript comprising from 5' to 3' the first lariat-forming sequence, the specific oligonucleotide, and the second lariat-forming sequence; and wherein the transcript is predicted to from a stable lariat structure by Watson-Crick base pairing between the nucleotides of the first lariat-forming region and the second lariat-forming region.
Claim 18
Dependent Claim 94 words
The oligonucleotide generator of claim 4, further comprising two oligonucleotides operably linked and position of either side of the termination sequence such that the first 20 nucleotides downstream of the specific nucleotide sequence on the sense strand is identical to the final 20 nucleotide of the 3' portion of the human U6 gene: 5' GTCCTAGGCTTTTGCACTTTT 3'(SEQ ID NO:8); wherein the U6-type RNA polymerase III promoter is the U6 promoter; and wherein the first hairpin-forming sequence and the capping segment of the transcript consist of the first 25 nucleotides of the naturally-occurring human U6 transcript.
Claim 19
Dependent Claim 22 words
The oligonucleotide generator of claim 16, wherein the sense strand of the specific nucleotide sequence is U6ON: 5' TCGACTCCTCTTCCTCCTCCACCTCCTCCTCCCATGCA 3'(SEQ ID NO:1).
Claim 20
Dependent Claim 25 words
The oligonucleotide generator of claim 2, further comprising a viral vector capable of inducing integration of the oligonucleotide into a chromosome of a target cell.
Claim 21
Dependent Claim 27 words
A method for generating oligonucleotides intracellularly, comprising administering an oligonucleotide generator of claim 2, in a form that permits entry of the oligonucleotides into a target cell.
Claim 22
Dependent Claim 27 words
A method for continuously generating oligonucleotides intracellularly, comprising administering an oligonucleotide generator of claim 18 in a form that permits entry of the oligonucleotides into a cell.
Claim 23
Dependent Claim 39 words
A generator vector, comprising from 5' to 3': (a) a U6-type promoter; (b) a stabilizing region from which a hairpin-forming sequence can be transcribed; and (c) a termination sequence; wherein the components of the generator vector are operably linked.
Claim 24
Dependent Claim 39 words
A generator vector, comprising from 5' to 3': (a) a U6-type promoter; (b) a stabilizing region from which a hairpin-forming sequence can be transcribed; and (c) a termination sequence; wherein the components of the generator vector are operably linked.
Claim 25
Dependent Claim 44 words
The generator vector of claim 21, further comprising from 5' to 3': a first restriction enzyme site; and a second restriction enzyme site; wherein the first and second restriction enzyme sites are operably linked and positioned between the stabilizing region and the termination sequence.
Claim 26
Dependent Claim 39 words
The generator vector of claim 22, further comprising a capping segment selected from the group consisting of ATATCC and ATATAC; wherein the capping segment is operably linked and positioned between the stabilizing region and the first restriction enzyme site.
Claim 27
Dependent Claim 41 words
The generator vector of claim 23, wherein the U6-type promoter is the human U6 promoter; wherein the hairpin-forming sequence of the transcript consist of the first 20 nucleotides of the naturally-occurring human U6 transcript; and wherein the capping segment is ATATCC.
Claim 28
Dependent Claim 27 words
The generator vector of claim 24, wherein the first restriction enzyme site is an XhoI site; and wherein the second restriction enzyme site is an NsiI site.
Claim 29
Dependent Claim 59 words
The generator vector of claim 24, further comprising two oligonucleotides operably linked and position of either side of the termination sequence such that the first 20 nucleotides downstream of the second restriction enzyme site on the sense strand is identical to the final 20 nucleotide of the 3' portion of the human U6 gene: 5' GTCCTAGGCTTTTGCACTTTT 3'(SEQ ID NO:7).
Claim 30
Independent Claim 55 words
A method of measuring triplex formation, which method comprises: (a) attaching a single-stranded nucleic acid to a solid support; (b) contacting the solid support with a fluid comprising a labeled double-stranded probe; (c) separating the unbound probe from the solid support; and (d) quantifying the amount of labeled double-stranded probe bound to the solid support.
Claim 31
Independent Claim 55 words
A method of measuring triplex formation, which method comprises: (a) attaching a single-stranded nucleic acid to a solid support; (b) contacting the solid support with a fluid comprising a labeled double-stranded probe; (c) separating the unbound probe from the solid support; and (d) quantifying the amount of labeled double-stranded probe bound to the solid support.
Claim 32
Independent Claim 55 words
A method of measuring triplex blotting, which method comprises: (a) attaching a double-stranded nucleic acid to a solid support; (b) contacting the solid support with a fluid comprising a labeled single-stranded probe; (c) separating the unbound probe from the solid support; and (d) quantifying the amount of labeled single-stranded probe bound to the solid support.
Claim 33
Independent Claim 55 words
A method of measuring triplex blotting, which method comprises: (a) attaching a double-stranded nucleic acid to a solid support; (b) contacting the solid support with a fluid comprising a labeled single-stranded probe; (c) separating the unbound probe from the solid support; and (d) quantifying the amount of labeled single-stranded probe bound to the solid support.

References Cited (Backward Citations)

US5190931A Cited
US5272065A Cited
US5316930A Cited
EP0601585A2 Cited
WO1995006718A2 Cited
WO1995006744A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-04-28 2000-10-28 2001-04-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-04-28 2004-10-28 2005-04-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-04-28 2008-10-28 2009-04-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag